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CRISPR/Cas9 editing reveals novel 
mechanisms of clustered microRNA 
regulation and function
Lazaros Lataniotis1, Andreas Albrecht2, Fatma O. Kok3, Clinton A. L. Monfries4, Lorena 
Benedetti5, Nathan D. Lawson3, Simon M. Hughes  4, Kathleen Steinhofel6, Manuel Mayr  1 
& Anna Zampetaki1
MicroRNAs (miRNAs) are important regulators of diverse physiological and pathophysiological 
processes. MiRNA families and clusters are two key features in miRNA biology. Here we explore the 
use of CRISPR/Cas9 as a powerful tool to delineate the function and regulation of miRNA families and 
clusters. We focused on four miRNA clusters composed of miRNA members of the same family, homo-
clusters or different families, hetero-clusters. Our results highlight different regulatory mechanisms in 
miRNA cluster expression. In the case of the miR-497~195 cluster, editing of miR-195 led to a significant 
decrease in the expression of the other miRNA in the cluster, miR-497a. Although no gene editing was 
detected in the miR-497a genomic locus, computational simulation revealed alteration in the three 
dimensional structure of the pri-miR-497~195 that may affect its processing. In cluster miR-143~145 our 
results imply a feed-forward regulation, although structural changes cannot be ruled out. Furthermore, 
in the miR-17~92 and miR-106~25 clusters no interdependency in miRNA expression was observed. Our 
findings suggest that CRISPR/Cas9 is a powerful gene editing tool that can uncover novel mechanisms 
of clustered miRNA regulation and function.
MicroRNAs (miRNAs) are small non coding RNAs that control gene expression posttranscriptionally1. In the car-
diovascular diseases and in cancer, miRNAs have emerged as prominent regulators in disease initiation and pro-
gression. Circulating miRNA signatures were also shown to associate with cardiovascular risk and were proposed 
as a novel mechanism of intercellular communication2–4. Several of the identified miRNAs with key functions in 
the cellular responses are organized in miRNA clusters5. These consist of multiple miRNAs located at the same 
chromosomal locus that are transcribed as a single primary miRNA transcript. The formation of structural clus-
ters was proposed to enhance stability by preventing immediate degradation and ensuring biogenesis of miRNAs 
that regulate a similar set of genes thus having direct functional implications6. In many cases, clustered miRNAs 
belong to the same miRNA family7, 8 forming a homo-cluster. Such miRNAs have identical ‘seed region’ and share 
a high degree of sequence homology that leads to functional redundancy9, 10 but also poses a serious limitation in 
miRNA research11.
CRISPR/Cas9 is an RNA-guided gene editing platform that is simple to design, highly specific and easy to 
use12, 13. It consists of a sole nuclease (Cas9) that identifies a conserved three nucleotide proto-adjacent motif 
(PAM) and cleaves both DNA strands thus creating a double stranded break (DSB). The CRISPR RNA (crRNA) 
is a short RNA with variable sequence that in combination with an adaptor trans-activating RNA (tracrRNA) 
acts as a guide for Cas9. The crRNA and tracrRNA can be fused to create the single-guide RNA (sgRNA)14. This 
is a highly flexible and easy to design short RNA molecule that can direct Cas9 to any target in the immediate 
vicinity of the PAM sequence by altering only the 20-nt guide sequence within the sgRNA. Once in complex, the 
Cas9-sgRNA will interrogate the DNA. Upon binding to the PAM, the Cas9-sgRNA complex detects DNA com-
plementarity to the guide RNA and cleaves each DNA strand to generate a blunt DSB, usually, at a position three 
base pairs from the PAM15, 16. Initial reports demonstrated the feasibility of using the CRISPR/Cas9 platform in 
targeting miRNA expression albeit inducing a varying degree of inhibition17, 18. Further studies improved the 
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efficiency19–21. In vivo, the CRISPR/Cas9 platform was used to delete a 53-kb fragment and generate knockout 
mice to elucidate the function of the largest miRNAs cluster in mice22, while the first miRNA double knock-
out mice using the CRISPR/Cas9 system have also been reported23. Recently, a robust approach to establish a 
multiplex system to achieve targeting of entire miRNA families was developed24. CRISPR/Cas9 technology also 
emerged as a powerful platform to identify new regulators of the miRNA pathway25 and RNA binding proteins 
involved in miRNA biogenesis26.
In the present study we explore the use of gene editing to delineate clustered miRNA regulation. To this end we 
employed the CRISPR/Cas9 system and determined the effect of gene editing in four miRNA clusters composed 
of miRNAs belonging to the same or distinct families. Our findings indicate that CRISPR/Cas9 is a powerful tech-
nology that can provide novel insights into the structural constraints and mechanisms regulating the expression 
of clustered miRNAs.
Materials and Methods
Cell culture. Vascular Smooth muscle cells (VSMCs) were isolated by enzymatic digestion of mouse aortas, 
as described elsewhere27 and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, ThermoFisher Scientific, 
Runcorn, UK) supplemented with 10% heat-inactivated Foetal Bovine Serum (FBS), 2 mM L-glutamine and 1% 
penicillin/streptomycin (100 U/ml penicillin and 100 µg/ml streptomycin), at 37 °C in a humidified atmosphere 
of 95% air/5% CO2. VSMCs were plated on gelatin coated flasks (0.04% in DMEM, ThermoFisher Scientific, 
Runcorn, UK) and subcultured with a ratio of 1:3 every 3 days. Human Embryonic Kidney (HEK) 293 T cells 
(HEK 293 T) were obtained from ATCC (CRL-3216). The cells were cultured in DMEM, supplemented with 10% 
FBS, 2 mM L-glutamine and 1% penicillin/streptomycin (100 U/ml penicillin and 100 µg/ml streptomycin) and 
subcultured with a ratio of 1:3 or 1:4 every 2–3 days28.
All methods were carried out in accordance with the institutional guidelines and regulations. All experimental 
protocols were approved by the KCL licensing committee.
Single Guide RNA Design and In Vitro Transcription (IVT). The online guide design tool (http://crispr.
mit.edu) was used to identify sgRNAs. The DNA sequence corresponding to the transcript annotated in miRBase 
v21 as stem loop miRNA was used as input sequence to design sgRNAs (Supplementary Table 1). The high-
est scoring guides, which targeted sequences either in or close to the miRNA stem-loop, were selected. In vitro 
transcription (IVT) was performed using the GeneArt Precision sgRNA Synthesis Kit (ThermoFisher Scientific, 
Runcorn, UK) according to manufacturer’s recommendations. The DNA template of the sgRNA was PCR assem-
bled and used to generate the sgRNAs by IVT. All IVT target primer sets and PCR primers are provided in 
Supplementary Table 2.
Lentiviral particle transduction. To confer Cas9 expression in VSMCs we used the LentiCRISPRv2 vector 
(Addgene, #52961) that encodes a Streptococcus pyogenes Cas9 (SpCas9) under the control of an elongation 1a 
short promoter (EFS)29. Lentiviral particles were produced using the lentiviral vector LentiCRISPRv2 and packag-
ing plasmids pMD2.G and psPAX2 (Addgene, #12259, #12260) as described previously30. Transfection complexes 
were formed using Viafect (Promega). Following a 6 h incubation, the medium was replaced with 8 ml of DMEM 
with 10% FBS and antibiotics supplemented with 1% Bovine Serum Albumin (Sigma-Aldrich). After 60 h, the 
lentiviral supernatant was collected, centrifuged at 1000 rpm for 5 min and filtered through 0.45 µm VWR Syringe 
Filters. A p24 antigen ELISA (Cell Biolabs) was used to determine the viral titer31.
Lentiviral Infection. VSMCs were seeded at a density of 200.000 cells per T25 flask. The following day cells 
were infected with lentiviral particles (1.6–2.4 × 107 TU/ml)31. The media were supplemented with 8 μg/ml of 
Polybrene (Sigma-Aldrich) and cells were incubated for 24 h with the viral supernatant. Fresh media was then 
added to the cells. Infected cells were puromycin selected (2 μg/ml from ThermoFisher Scientific, Runcorn, UK) 
for 48 h32.
Genome editing of VSMCs. To induce gene editing, VSMCs expressing Cas9 were transfected with IVT 
sgRNA using LipofectamineRNAiMAX (ThermoFisher Scientific, Runcorn, UK) according to the company’s rec-
ommendations. In brief, VSMCs were seeded in 6 well plates at a cell density of 150.000 cells/well in complete 
medium with no antibiotics. The following day, cells were transfected with 65 pmole of IVT sgRNA33. Equimolar 
concentration of a tracrRNA was transfected in control cells. After 24 hours, fresh media were added to the cells 
and two days later the editing efficiency was determined.
Genomic PCR and Sanger Sequencing. Genomic DNA extraction was performed using QuickExtract 
DNA Extract Solution (Epicentre) according to manufacturer’s recommendations. Briefly, cells were lysed in 
200 µl of the extraction solution and incubated at 65 °C for 20 min. Subsequently, samples were heated at 96 °C for 
10 min and stored at −20 °C. The genomic loci of interest were amplified by PCR using Kapa HiFi PCR kit Hot 
start (Kapa Biosystems). The PCR amplicons were then column purified (ThermoFisher Scientific, Runcorn, UK). 
Genomic PCR primer sequences are provided in Supplementary Table 2. To determine the mutation pattern, 
purified PCR amplicons were cloned into the pGEM-T Vector (Promega). Random colonies were PCR screened 
and submitted for Sanger sequencing using the T7 primer (TAATACGACTCACTATAGGG).
T7 Endonuclease I Assay. To assess the gene editing efficiency, the T7 Endonuclease I assay (T7EI) was 
employed as described recently34. Briefly, 90 ng of the purified PCR product in 1x KAPA HiFi GC Buffer were used 
for the reannealing reaction. PCR products were denatured by heating to 95 °C for 10 min and then re-annealed 
by slowly ramping down the temperature to 25 °C by a rate of 4.5% per min. Subsequently, samples were sup-
plemented with 0.5 U of T7EI (NEB, Hitchin, UK) and incubated at 37 °C for 1 h. As a final step, one volume of 
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Purple Loading Buffer (NEB, Hitchin, UK) was added and the reaction was quenched by heating to 70 °C for 
10 min. To visualize the T7EI digestion products, a 2% agarose gel in 1xTBE buffer was prepared and stained with 
SYBR Gold Nucleic Acid Gel Stain. The gel was visualized using the Ettan DIGE Imager by GE HealthCare. The 
T7EI results were quantified using the ImageJ software. The editing efficiency was calculated using the following 
formula28:
= − − + + + ×Indel (%) (1 (1 (B C/A B C)) ) 100,1/2
where, A = uncut DNA substrate, B, C = digestion products
To assess the gene editing in putative offtarget sites, genomic PCR amplification of the respective loci 
(Supplementary Table 3) followed by T7EI assay was performed. Both the CRISPR Design tool (Zhang lab, MIT) 
and the CRISPR Finder (Welcome Trust Sanger Institute) were used to identify potential offtargets.
Restriction Enzyme Digestions. Restriction enzymes (all from NEB) were also used to assess gene edit-
ing. Digestion reactions for all restriction enzymes were incubated at 37 °C for 1 h in CutSmart Buffer with the 
exception of SspI that was incubated in NEB Buffer 2.1. Digestion products were visualised in 2% agarose gel in 
1xTBE buffer.
RNA extraction. Total RNA from cultured cells was prepared using the miRNeasy kit (Qiagen) as described 
previously35. In brief, cells were lysed with 700 μl of QIAzol reagent. Following a brief incubation at ambient tem-
perature, 140 μl of chloroform were added and the solution was mixed vigorously. The samples were then centri-
fuged at 12,000 rpm for 15 min at 4 °C. The aqueous phase was carefully transferred to a new tube and 1.5 volumes 
of ethanol were added. The samples were applied directly to columns and washed according to the company’s 
protocol. Total RNA was eluted in 25 μl of nuclease free H2O
MiRNA quantification. A total of 100 ng of RNA were reverse transcribed using the Megaplex Rodent 
Primer Pools A as previously described27. The reverse transcription (RT) reaction was performed according to the 
company’s recommendations (0.8 µl of Pooled Primers were combined with 0.2 µl of 100 mM dNTPs with dTTP, 
0.8 µl of 10x Reverse-Transcription Buffer, 0.9 µl of MgCl2 (25 mM), 1.5 µl of Multiscribe Reverse-Transcriptase 
and 0.1 µl of RNAsin (20 U/µl) to a final volume of 7.5 µl). The RT reaction was set as follows: 16 °C for 2 min, 
42 °C for 1 min and 50 °C for 1 sec for 40 cycles and then incubation at 85 °C for 5 min using a Veriti thermocycler 
(ThermoFisher Scientific, Runcorn, UK). The RT reaction products were diluted to 1 ng/µl corresponding RNA 
and stored at −20 °C. Taqman miRNA assays were used to assess the expression of mature miRNAs. For the 
quantitative polymerase chain reaction (QPCR) reaction, 2.25 µl of Megaplex reverse transcription product were 
combined with 0.25 µl of 20x Taqman miRNA Assay (ThermoFisher Scientific, Runcorn, UK) and 2.5 µl of the 
2x Taqman Universal PCR Master Mix No Amp Erase UNG (ThermoFisher Scientific, Runcorn, UK) to a final 
volume of 5 µl. QPCR was performed on a Viia7 thermocycler at 95 °C for 10 min, followed by 40 cycles of 95 °C 
for 15 sec and 60 °C for 1 min. U6 was used as a normalization control.
MiRNA Overexpression. Cells were plated at 60–70% confluency on the day before transfection. Mouse 
miRNA mimics and a nontargeting control were obtained by ThermoFisher Scientific, and transfected at a final 
concentration of 20 nM using Lipofectamine RMAiMAX (ThermoFisher Scientific, Runcorn, UK) as described 
previously27.
Gene expression. QPCR was used to assess the gene expression levels. In these studies, 1 μg of RNA was 
reversed transcribed into cDNA using the High Capacity Reverse Transcriptase kit (ThermoFisher Scientific, 
Runcorn, UK). Prior to pri-miRNA assessment RNA samples were treated with DNAse for 30 min at 37 °C, to 
remove any genomic DNA contamination in the preparations. For all genes, Taqman Assays were used with 
the exception of Carmn that was assessed using specific primers36 (Supplementary Table 2) and SyBr Select 
Mastermix (ThermoFisher Scientific, Runcorn, UK). Beta Actin was used as a normalization control.
Computational analysis. Secondary structures without pseudoknots were generated by RNAfold 
(Vienna RNA tools, http://rna.tbi.univie.ac.at/cgi-bin/RNAWebSuite/RNAfold.cgi) using the Turner model 
(Standard settings), while secondary structures with pseudoknots were generated by vsfold537 (Chiba Institute of 
Technology, Japan, http://www.rna.it-chiba.ac.jp/~vsfold/vsfold5/) and Settings: 37 °C temperature; Kuhn length 
6; Jacobson-Stockmayer gamma = 1.75 and contiguous stems = 6. Visualization of the secondary structures with 
pseudoknots was performed using the Pseudoviewer software (Inha University, S Korea http://wilab.inha.ac.kr/
pseudoviewer/). The RNAComposer38 (Poland, http://rnacomposer.cs.put.poznan.pl/) was used to generate the 
pbd-files through molecular RNA simulation from vsfold5 output. The RNAComposer output pdb-files were then 
input to pyMOL to generate high quality 3D images. MiR-497a stem loop is depicted in green and its’ terminal 
loop in magenta. MiR-195a stem loop is depicted in red and its’ terminal loop in yellow.
Statistical analysis. Statistical analyses were performed with the Student t-test with a Bonferroni post hoc 
test or ANOVA with Dunnett post hoc test, using GraphPad Prism 5 software. Results are shown as mean ± SD. 
A value of P < 0.05 was considered significant.
Results
Gene Editing of the MiR-497~195 Cluster. Cluster miR-497~195 is a homo-cluster composed of two 
members of the miR-15 family, miR-497a and miR-195a. The antisense strand encodes miR-497b, a miRNA that 
displays high homology with miR-497a but does not harbour the same seed sequence. In mice, the miR-15 family 
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consists of miRNAs that display an identical seed region and high sequence homology overall9, 27, 39 (Fig. 1a, 
Supplementary Figure S1). MiR-195a has a prominent role in vascular remodelling and extracellular matrix depo-
sition. Differential expression of miR-195 was also detected in the aneurysmal tissue while miR-195 manipulation 
was shown to regulate tissue remodelling27.
To determine whether targeting of the miR-195a hairpin could have an effect on the miR-497~195 cluster, we 
generated VSMCs stably expressing Cas9 nuclease. Guide RNA was designed using the online CRISPR Design 
Tool (http://tools.genome-engineering.org). The DNA sequence corresponding to the transcript annotated in 
miRBase v21 as stem loop miRNA was used as input sequence to design sgRNAs. The identified sg195m2 guide 
generates a DSB in the miR-195a stem loop that disrupts the SspI restriction digestion site (Fig. 1a, Supplementary 
Figure S1). Transfection of sg195m2 guide to VSMCs stably expressing Cas9 induced substantial gene edit-
ing (28–30%) as assessed by the T7 endonuclease I (T7EI) assay that identifies and cleaves mismatched DNA 
(Fig. 1b). As expected, editing of the locus led to disruption of the SspI restriction site and an altered digestion 
pattern (Fig. 1c). Mutation screening using Sanger sequencing demonstrated a panel of indels, mostly deletions, 
in the miR-195a locus (Fig. 1d). Using the RNAfold prediction tool, substantial alterations of the secondary struc-
ture of the miR-195a stem loop in mutants was identified (Supplementary Figure S1).
QPCR quantification indicated a 55% downregulation of the mature miR-195a expression in cells transfected 
with the sg195m2 guide (Fig. 1e), suggesting that editing of the locus led to a significant reduction in miR-195a 
expression. At the same time, no difference in miR-15a, miR-15b or miR-16 was observed indicating that the 
genomic editing did not lead to inhibition of the entire miR-15 family. No compensatory miRNA expression 
was observed either (Fig. 1e). MiR-497b was not expressed in VSMCs. Intriguingly, miRNA inhibition was not 
entirely specific, as a significant downregulation (62%) in miR-497a expression was observed (Fig. 1e). MiR-195a 
and miR-497a form a cluster on chromosome 11, are transcribed as one primary transcript, with both stem loops 
located within 500 bp. To determine whether the observed miR-497a downregulation was due to unexpected 
gene editing of the miR-497a genomic locus, we performed a T7EI assay. No specific T7 digestion products 
were detected suggesting that there is no editing in the locus (Fig. 1f). Further support to this notion was pro-
vided by Sanger sequencing as no mutations were detected (Supplementary Figure S2). Noteworthy, no editing 
in a panel of potential offtarget sites as predicted by the CRISPR Design tool (Zhang lab, MIT) and CRISPR 
Finder (Welcome Trust Sanger Institute) was detected (Supplementary Table 3, Supplementary Figure S3). Similar 
results were obtained using different guide (sg195 m3) to induce gene editing of the miR-195a stem loop. The 
significant downregulation of miR-195a was accompanied by a significant decrease in miR-497a expression levels 
(Supplementary Figure S4) with no editing in the miR-497 genomic locus (Supplementary Figure S5). No editing 
in potential offtarget sites for sg195 m3 was observed either (Supplementary Figure S5).
Downregulation of miR-497a may occur as a secondary effect due to the reduced levels of mature miR-195a. 
To determine whether the mature miR-195a expression was affecting the mature miR-497a or the miR-497a 
stem loop levels, gain and loss of function experiments can be performed. In miR-195a inhibition however, the 
sequence similarities between miR-195a and miR-497a indicate that the inhibitor can effectively silence both 
miRNAs (Supplementary Figure S6) and thus no conclusive data can be obtained. Overexpression of a miRNA 
can be achieved using short synthetic oligonucleotides that function as mature miRNA without requiring any 
processing by the Drosha or Dicer complexes. Following miR-195a overexpression using miRNA mimics, no 
differences on the expression of the mature miR-497a were observed (Fig. 1g), suggesting that the miR-497a 
expression is not controlled by miR-195a.
MiRNA biogenesis may depend on the primary miRNA structure and the accessibility of the stem loops to 
the enzymatic complexes of Drosha and Dicer40. Therefore we performed a computational analysis to determine 
whether structural constraints could impede the processing of the mutant primiRs. We focused on the analysis 
of the mutant 1 that harbours a deletion of 1 nucleotide (mut1), mutant 5 that harbours a deletion of 18 nucleo-
tides (mut5) and the unedited transcript (wt). We used three software prediction programmes (RNAfold, Sfold, 
Co-fold) and all of them returned identical results. Secondary structures without pseudo-knots can be described 
as outerplanar graphs as they are 2D representations traversing the structure along backbone bonds that leave all 
hydrogen bonds at the same side of the direction (either all left-hand side or all right-hand side). Secondary struc-
tures with pseudo-knots expand significantly the search space for robust conformations and the above-mentioned 
property is no longer valid. Noteworthy, finding 2D presentations of structures with pseudo-knots by avoiding 
‘crossing edges’ is much more complicated algorithmically than outerplanar representations. Interestingly, in our 
case the secondary structure predictions with pseudoknots indicated that wt and mut1 were similar but quite 
different from mut5 (Supplementary Figures S7 and S8).
The 3D simulation however highlighted clear differences. In the wt, the miR-195a stem loop was prominent 
while the miR-497a stem loop more compressed but clearly accessible. In the mut1, the conformation of miR-
195a stem loop was similar although the single nucleotide mutation had an effect leading to a miR-497a stem loop 
now strongly attached to the main core and not as accessible as in wt. Nevertheless, profound differences were 
observed in the conformation of mut5. No typical hairpin for primiR-195a could be detected and the structure 
was more strongly entangled with the main core. The miR-497a stem loop displayed a compact shape in close 
proximity with the miR-195a stem loop but relatively distal from the main core and with no clear accessibility 
to the hairpin (Fig. 2). A movie reconstruction of the tertiary structure of the wt and mutant primiR-497~195 
is provided in Supplementary Figure S9. Overall, the 3D remodelling indicates a clear difference between the 
entire structure of wt and mut5 and to a lesser extent also between wt and mut1 with accessibility of the miR-497a 
stem loop being affected in both mutants. These results suggest that extensive deletions (in this case 18 nt) in the 
genomics locus of miR-195 stem loop can alter the tertiary structure of the entire miR-497~195 transcript.
Gene Editing of the MiR-143~145 Cluster. To determine the effect of gene editing in a hetero-cluster we 
focused on the miR-143~145 cluster41. This locus that spans ~1400 bp in mice harbours miR-143 and miR-145a, 
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Figure 1. Gene editing of the miR-195a locus. (a) The genomic locus of the miR-497~195 cluster. MiR-195a 
forms a cluster with miR-497a and is transcribed as a single primary transcript. MiR-497b is encoded by the 
antisense strand and displays high homology with miR-497a but does not harbour the same seed sequence. 
Right panel, miR-15 family members share a common seed region (highlighted in grey) and display high 
sequence homology. (b) T7EI assay for the miR-195a locus. Three independent experiments were performed. 
ND: non detectable (c) The sg195m2 targets the miR-195a genomic locus and disrupts an SspI restriction site. 
Asterisks (*) indicate differential digestion products. (d) Sanger sequencing of the edited miR-195a genomic 
locus revealed the presence of random indels, mainly deletions, represented as dashes. The PAM sequence is 
highlighted in grey. Insertions are shown in bold small case fonts. N/A: Not Applicable. (e) Gene editing of 
the miR-195a locus resulted in the down-regulation of both miR-195a and miR-497a without affecting the 
expression of other members of the miR-15 family as assessed by qPCR. MiR-497b that is also encoded in the 
miR-497~195 cluster is not expressed in VSMCs. U6 was used as a normalization control. n = 3, *p < 0.05 
Student’s t-test with Bonferroni post hoc test (f) T7EI assay for miR-497a genomic locus did not reveal any 
editing in the genomic locus of miR-497, *nonspecific T7EI digestion product. (g) QPCR quantification of 
mature miR-195a and miR-497a expression, following overexpression of miR-195a using miRNA mimics. U6 
was used as a normalization control. n = 3, *p < 0.05 Student’s t test.
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two miRNAs that do not share sequence similarities (Fig. 3a, Supplementary Figure S10) but regulate essential 
functions for VSMCs growth, differentiation, and contractility42, 43. Two sgRNAs targeting the miR-145a locus 
were designed. Sg145m2 guide targets the miR-145a stem loop and disrupts a HinfI restriction site, while sg145m1 
guide generates a DSB in close proximity, 30 bp upstream of the miR-145a stem loop (Fig. 3a, Supplementary 
Figure S10). T7EI results indicate that the sgRNA145m1 guide was more efficient in inducing gene editing with 
indels ranging from 47–57%, while sgRNA145m2 displayed editing efficiency of 24–29% (Fig. 3b). Digestion with 
Figure 2. Effect of CRISPR/Cas9 editing in the tertiary structure of miR-497~195 cluster. Computational 
simulation of the 3D structure (generated by vsfold5 - with pseudoknots – as input to RNAComposer, pdb-file 
visualised by PyMOL) of the primiR-497~195 in unedited (wt), mutant harbouring a deletion of 1 nt (mut1) and 
a mutant harbouring a deletion of 18 nt (mut5). MiR-497a stem loop is depicted in green and its’ terminal loop 
in magenta. MiR-195a stem loop is depicted in red and its’ terminal loop in yellow.
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HinfI confirmed the editing following sg145m2 guide introduction (Fig. 3c). Sanger sequencing demonstrated 
small indel formation (1–40 bp) with either sgRNA (Fig. 3d,e).
Gene editing had a robust effect on miRNA expression. A strong inhibition of mature miR-145a and miR-
143 (89% and 50%, respectively) expression was observed following sg145m2 application (Fig. 4a). Interestingly, 
despite the high levels of gene editing induced by the sgRNAm1 guide the downregulation in mature miR-145a 
and miR-143 expression was significant but lower than sgRNAm2 (33% and 28%, respectively), suggesting that 
targeting directly the stem loop is a more efficient strategy for inhibiting miRNA expression (Fig. 4a). Further 
Figure 3. Gene editing of the miR-145a locus. (a) The genomic locus of the miR-143~145 cluster. MiR-145a 
forms a cluster with miR-143 and is transcribed as a single primary transcript. Right panel, miR-145 and miR-
143 do not share a common seed region (highlighted in grey) and display no sequence homology. (b) T7EI assay 
for the miR-145a locus. Three independent experiments were performed. ND: non detectable (c) The sg145m2 
targets the miR-145 genomic locus and disrupts an SspI restriction site. Asterisks (*) indicate differential 
digestion products. (d,e) Sanger sequencing of the edited miR-145a genomic locus using sg145m1 and 
sg145m2, respectively. The PAM sequence is highlighted in grey. Deletions are represented as dashes, insertions 
are shown in bold small case fonts. N/A: Not Applicable.
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support to this notion was provided by Sanger sequencing. The sg145m1 guide led to indels that did not disrupt 
the miR-145a stem loop sequence, while sg145m2 guide led to mutations in the miR-145a stem loop that also alter 
its secondary structure (Supplementary Figure S10). Despite the significant decrease in miR-143 expression, no 
editing of the miR-143 genomic locus was observed with either guide (Fig. 4b). Mutation screening revealed no 
indels in the miR-143 locus in edited cells with either guide (Supplementary Figure S11). Intriguingly, the expres-
sion of Carmn (cardiac mesoderm enhancer-associated non-coding RNA), a long non coding RNA overlapping 
the miR-143~145 cluster (Supplementary Figure S12, Fig. 4c) that constitutes an independent transcription unit36 
did not differ in miR-145 edited cells confirming that only the primary transcript (primiR-143~145) is affected. In 
regards to the tertiary structure of the cluster miR-143~145, as it is length is about 1400 bp, it cannot be analysed 
Figure 4. Effect of CRISPR/Cas9 editing of the miR-143~145 cluster on miRNA expression. (a) QPCR 
quantification of mature miRNA expression following gene editing of the miR-145a locus. U6 was used as a 
normalization control. n = 3, *p < 0.05 (ANOVA with Dunnett post hoc test) (b) T7EI assay for the miR-143 
genomic locus. *nonspecific T7EI digestion product. (c) QPCR quantification of Carmn in sg145m2 edited 
cells. Beta actin was used as a normalization control. (n = 3) (ANOVA with Dunnett post hoc test) (d) QPCR 
quantification of the primiR-143~145 expression in sg145m2 edited cells. Pri-miRNA Taqman assays that 
are specifically designed to amplify flanking sequences within 500 base pairs on either side of the stem loop 
were used. Beta actin was used as a normalization control. n = 3, *p < 0.05. (e) The expression of the mature 
miR-143 and primiR-143~145, following miR-145a overexpression with miR-145a mimics, was quantified by 
qPCR. Kruppel Like Factor 4 (KLF4), a validated target of miR-145a was also assessed. Beta actin was used as a 
normalization control. n = 3, *p < 0.05 (ANOVA with Dunnett post hoc test).
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using the algorithms currently available for the computational simulation. The development of more elegant tools 
to predict the tertiary structure of longer sequences will provide further insights.
To elaborate on the regulatory mechanisms involved, we quantified the expression of primiR-143 and 
primiR-145 in sg145m2 edited cells. To this end, we used commercially available assays that are designed to target 
the flanking sequences on either side of the miRNA stem loop. In essence, the primiR-143 and primiR-145a assays 
that we used targeted the hairpin of miR-143 and miR-145a, respectively. A sharp decrease was observed indicat-
ing that targeting miR-145a affects the expression of the entire primiR-143~145 (Fig. 4d).
In order to determine whether mature miR-145a expression exerts transcriptional control on the miR-
143~145 cluster, we overexpressed miR-145a in VSMCs using miRNA mimics. These are short synthetic oligo-
nucleotides that function as mature miRNA without requiring any processing by the Drosha or Dicer complexes. 
High levels of miR-145a led to increased miR-143 expression (250%) that was accompanied by a coordinated 
increase in primiR-143 and miR-145a expression (162% and 165% respectively), indicating transcriptional reg-
ulation. As expected the levels of KLF4, a validated target of miR-145a41 were significantly downregulated (40%) 
following miR-145a overexpression (Fig. 4e). These data suggest that the CRISPR/Cas9 editing technology is 
extremely precise, indels occurred only in the vicinity of the DSB as no mutations were identified in a 1400 bp 
region that encodes the cluster. The use of CRISPR/Cas9 platform for miRNA inhibition can reveal novel regula-
tory mechanisms for clustered miRNA expression.
Gene Editing of the MiR-17~92 and MiR-106~25 Clusters. We next focused on two highly studied 
miRNA clusters in the mouse genome, namely miR-17~92 and miR-106b~25 spanning 800 bp and 300 bp respec-
tively. The miR-17~92 cluster plays a pivotal role in the cardiovascular system and in cancer and mediates pro-
cesses such as angiogenesis10, 44. This cluster consists of six miRNAs that can be grouped in four families based on 
their seed sequence (Fig. 5a, Supplementary Figure S13). Intriguingly, two paralogs, the miR-106a~363 and miR-
106b~25 clusters believed to be derived from a series of duplication and deletion events during vertebrate evolu-
tion have been identified45. Gene editing using sg18 that targets the miR-18a stem loop (Figure 5a, Supplementary 
Figure S13) was efficient (32–37%) as assessed by T7EI assay (Fig. 5b) and disrupted the Bsp1286I restriction 
site (Fig. 5c). Sanger sequencing revealed the presence of small deletions in the miR-18a stem loop (Fig. 5d) that 
were predicted to induce a differential secondary conformation (Supplementary Figure S13). As previously, these 
deletions were very specific and occurred only in the vicinity of the DSB. No mutations were identified in a 1 kb 
region that encodes the cluster (Supplementary Figure S14). In the case of miR-17~92 cluster, the expression of 
miR-18a diminished robustly (88%) but there was no impact on miR-17, miR-19a and miR-20a levels, all miRNAs 
located in the cluster (Fig. 5e). The expression of miR-19b and miR-92a was not assessed as they are also encoded 
by a second miRNA cluster on chromosome X (Supplementary Table 1).
Similar results were obtained when the stem loop of miR-25 was targeted in the miR-106b~25 cluster (Fig. 6a, 
Supplementary Figure S15). Effective editing was observed with sg25 (20–27%) as determined by T7EI assay 
(Fig. 6b) or the disruption of the MfeI restriction digestion site (Fig. 6c, Supplementary Figure S15). Sanger 
sequencing demonstrated a mutation pattern of small indels (Fig. 6d) that led to alteration in the secondary struc-
ture of the miR-25 stem loop (Supplementary Figure S15). No editing was observed for the miR-93 and miR-106b 
loci (Supplementary Figure S16). QPCR quantification demonstrated a significant downregulation of miR-25 
expression (49%) in edited cells (Fig. 6e) while the levels of miR-93 and miR-106b were not affected.
Discussion
MiRNAs provide rapid responses to counteract rapid and variable fluctuations and safeguard the robustness of 
biological systems46. A large portion of miRNAs organise in miRNA clusters5. Computational analysis suggests 
that the existence of miRNA clusters is much higher than expected by chance5. Based on their regulation, they can 
be divided to homo-clusters, that are composed of miRNA members of the same family and control their targets 
in a single step thus resulting in a rapid regulation and hetero-clusters that are composed of miRNA members of 
different families that typically exert control of their targets in multiple steps in a more delayed response6. MiRNA 
clusters often undergo a series of duplication events that lead to the generation of paralogues that are thought to 
regulate a similar set of genes and have overlapping functions6.
Here we interrogated the use of gene editing as a tool to understand the clustered miRNA regulation. Our 
study focused on four clusters, the homo-cluster miR-497~195, the hetero-clusters miR-143~145 and miR-17~92 
and cluster miR-106b~25 a paralogue of cluster miR-17~92. The CRISPR/Cas9 system emerged as a very precise 
tool, inducing indel formation only in the vicinity of DSB. Our data demonstrate a diverse panel of regulatory 
mechanisms of expression for clustered miRNAs. Intriguingly, we found that in miR-497~195 cluster mutations 
in miR-195a hairpin can affect the expression of miR-497a that resides in the other hairpin of the same cluster. 
Computational analysis highlighted differences in the tertiary structure of the primiRNA for mutant with exten-
sive deletions that may contribute to the differential mature miRNA expression. Overall, we found that in spite 
of the sequence diversity of primiRNAs, mutations are well tolerated provided that they don’t disrupt critical 
elements such as stem length, bulge position and terminal loops. Furthermore, we demonstrate that although 
miRNAs in a cluster form co-transcriptional unit their expression is not always interdependent.
MiRNA maturation is a complex process. In the canonical pathway the first step is a cleavage event in the 
nucleus by RNAse III DROSHA and its co-factor DGCR8 forming the microprocessor, a bulky complex of 
364 kDa47. A very specific and precise recognition of the primiRNA by the microprocessor emerged in a model 
whereby a trimeric complex is formed encompassing one DROSHA that serves as a ruler by recognizing basal 
elements and two DGCR8 adaptors that interact with the apical elements to ensure fidelity of processing47. This 
modular model predicts varying contributions of several determinants that need to interact in a coordinated 
response for primiRNA recognition48.
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Elegant experimental approaches have identified additional recognition and processing features49, 50. 
Secondary structures such as stem length, hairpin pairing, bulge size and position and apical loop size were 
shown to contribute to effective miRNA biogenesis. Moreover, sequence motifs, such as a UG motif at the base of 
the hairpin and a UGU/GUG motif in the apical loop and a CNNC motif downstream of the hairpin, can enhance 
processing48, 49, 51. Importantly, these primary sequence motifs exert their effects in some primiRNAs but not in 
others and are thought to have an additive effect in primiRNA processing.
Figure 5. Gene editing of the miR-18a locus. (a) The genomic locus of the miR-17~92 cluster. Right panels, 
miRNAs in this cluster are derived from four different families that share different degrees of homology (seed 
region highlighted in grey). (b) T7EI assay for the miR-17~92 cluster. Three independent experiments are 
shown. ND: non detectable. Asterisks (*) indicate nonspecific T7EI digestion products. (c) The sg18 targets 
the miR-18a genomic locus and disrupts a Bsp1286I restriction site. Asterisks (*) indicate differential digestion 
products. (d) Sanger sequencing of the edited miR-18a genomic locus. The PAM sequence is highlighted in grey. 
Deletions are represented as dashes. Insertions are shown in bold small case fonts. N/A: Not Applicable. (e) 
QPCR quantification of mature miRNA expression following editing with sg18. U6 was used as a normalization 
control. n = 3, *p < 0.05 (Student’s t-test with Bonferroni post hoc test).
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An intricate set of rules and modifications that are preferentially utilized in miRNAs over non-miRNA hair-
pins were also uncovered50. An optimal stem length and two bulge depleted regions in the miRNA hairpin stem 
that may function as protein-interacting surfaces were proposed. The presence of bulges in the depleted sites 
was dimmed as detrimental. Moreover, the CNNC motif was found to be important for optimal length hairpins. 
These findings led to the prediction and experimental validation for a significant role of single-nucleotide poly-
morphisms (SNPs) in altering primiRNA processing and miRNA biogenesis in several occasions50. Adding to the 
complexity of miRNA biogenesis, RNA binding proteins (RBPs) can post-transcriptionally modify various steps 
Figure 6. Gene editing of the miR-25 locus. (a) The genomic locus of the miR-106b~25 cluster. Right panel, 
miRNAs in this cluster are derived from two different families that share varying degrees of homology (seed 
region highlighted in grey). (b) T7EI assay for the miR-106b~25 cluster. ND: non detectable. (c) The sg25 
targets the miR-25 genomic locus and disrupts a MfeI restriction site. Asterisks (*) indicate undigested 
amplicons. (d) Sanger sequencing of the edited miR-25 genomic locus. The PAM sequence is highlighted in 
grey. Deletions are represented as dashes, insertions are shown in bold small case fonts. N/A: Not Applicable. (e) 
QPCR quantification of mature miRNAs following editing with sg25. U6 was used as a normalization control. 
n = 6, *p < 0.05 (Student’s t-test with Bonferroni post hoc test).
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and affect the miRNA processing52. Employing a large scale biochemical screen, a stimulatory or inhibiting role 
for RBPs in miRNA processing was recently revealed26.
These findings are intriguing and imply that CRISPR/Cas9 gene editing of miRNA genes can affect processing 
of the hairpin in a dual manner. Directly through sequence alterations and disruption of sequence motifs but also 
structurally, through changes in the stem length, bulge size and position and terminal loop length. In the case of 
clustered miRNAs, our data imply that the tertiary structure may also contribute to the processing of the prim-
iRNA to individual mature miRNAs. Computational simulation demonstrated that disruption of the miR-195a 
stem loop may have imposed tertiary constraints that impede effective processing of the entire primary transcript 
leading to diminished mature miR-497a levels. In a bioinformatic reconstruction of a mutant miR-195a stem loop 
harbouring a 18nt deletion a clear difference was observed compared to the wild type. Noteworthy, a UGU/GUG 
motif in the apical loop is not present in the miR-195a stem loop. Nevertheless, a direct disruption of terminal 
loop both in terms of sequence and in length was detected in the secondary structure of the mutant. Our findings 
are in line with previous reports that demonstrated that mutations in the terminal loop abrogate efficient prim-
iRNA processing53. Further support to this notion is provided by studies that show an autoregulatory role for the 
tertiary structure of primiR-17~92 in its maturation40, 54 and binding of auxiliary factors to conserved terminal 
loops.
Mutation of primiRNA sequences are well tolerated provided that they do not disrupt critical elements. In 
the case of miR-143~145, introducing loxP sites for Cre-mediated recombination in the miR-143 or miR-145 
genomic loci resulted in miR-143 and miR-145a mutant mice that do not exhibit an effect on the expression of 
the miR-145a and miR-143 respectively43. On the other hand, replacing the miR-143 genomic region with a LacZ 
reporter disrupted miR-143 expression but also led to effective silencing of the miR-145a expression55. It is clear 
that the two approaches differ substantially. While both disrupt the miRNA gene, the introduction of a reporter 
in the clustered primary transcript renders it unsuitable for downstream processing and the maturation cascade 
for miR-145a generation, despite the presence of an intact miR-145a stem loop. It is tempting to speculate that in 
this case as well the tertiary structure functions as the critical determinant of mature clustered miRNA biogenesis. 
Nevertheless, it is clear that the introduction of mutations in the primiR-143~145 per se does not hamper miRNA 
maturation43. This is in line with our finding that sg145m1 has a minimal effect on miR-143 and miR-145a expres-
sion despite inducing effective editing of the locus.
Our findings imply a co-ordination in the maturation of clustered miRNAs. In the case of the miR-143~145 
cluster we also detected interdependency in the mature miRNA expression. Gene editing of miR-145a led to 
decreased expression of miR-145a and miR-143 and miR-145a mimics resulted in increased levels of primiR-143 
and mature miR-143 indicating transcriptional regulation and a feed-forward loop that reinforces the expression 
of the entire cluster. We provide direct evidence for the role of mature miR-145a in triggering the expression of 
the cluster miR-143~miR-145. Although it is difficult to dissect whether the differences in miR-143 expression in 
our edited cells are due to structural changes that hamper the processing of the cluster primiRNA or due to tran-
scriptional regulation triggered by the reduced miR-145a levels, the two possibilities are not mutually exclusive. 
It is important to point out that miR-143 and miR-145a show no sequence homology suggesting that they do not 
have common targets41. Nonetheless, both miRNAs act as part of a network that controls cytoskeletal remodelling 
and phenotypic switching of VSMCs under pathological conditions43. This underlines the added value of miRNA 
clusters that provide an effective mechanism of cellular response and may explain the evolutionary pressure for 
their sequence conservation.
Interestingly, interdependency in expression does not seem to be a common feature in all clustered miRNAs. 
Our gene editing in cluster miR-17~92 and miR-106b~25 revealed that targeting of miR-18a and miR-25 does not 
affect the expression of other miRNAs in each cluster. No compensatory increase of these miRNAs was observed 
in edited cells either. Overexpression of miR-195a also did not result in enhanced levels of miR-497a suggesting 
no interdependency in the miR-497~195 cluster. Thus it seems that while coordinated expression of miRNAs in 
clusters is a shared feature, feed-forward and feedback loops are in place only when a synergistic effect and com-
bined regulation of multiple pathways is required.
In conclusion, CRISPR/Cas9 emerged as a powerful tool to dissect the regulation and function of clustered 
miRNAs. The technology provides a unique platform to establish mutant cell lines or mouse models and elucidate 
the specific contribution of miRNA families in cellular responses both at baseline and following injury.
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